Welcome to the Podiatry Homepage
The Colorado Podiatry Board was instituted as part of the Podiatrists Practice Act in order to regulate the practice of podiatry in Colorado. The Board ensures that licensed professionals are acting in accordance with the standards of care as outlined in the Podiatrists Practice Act. Licensure is mandatory to practice podiatric medicine or perform podiatric surgery in Colorado or to treat Colorado patients.
The Podiatry Board is a Type I Board, meaning that it is policy autonomous and made up of professional and public members (four podiatrists and one public member). The decisions made by the Podiatry Board are not subject to administrative review. The Podiatry Board does not have the authority to arbitrate or adjudicate fee disputes.
Program Information
- Program/Board Members
Karen Phelan, Program Director
Colorado Podiatry Board
1560 Broadway, Suite 1350
Denver, CO 80202Phone: 303-894-7800 | Fax: 303-894-7764 | Email: dora_podiatryboard@state.co.us
Board Members:
- Staci Bogin, DPM, President
Professional Member | Term Expires: March 17, 2028 - Michael Vaardahl, DPM, Vice President
Professional Member | Term Expires: March 17, 2028 - Kristine Hoffman, DPM
Professional Member | Term Expires: March 17, 2027 - Brett D. Sachs, DPM
Professional Member | Term Expires: March 17, 2025 - Ora DeMorrow
Public Member | Term Expires: March 17, 2026
- Staci Bogin, DPM, President
- Public Notices
Rulemaking Hearing - November 3, 2023
The purpose of this Permanent Rulemaking Hearing is to allow stakeholders a final opportunity to testify before the Director determines whether to repeal on a permanent basis Rule 1.20 - PROVISION OF REPRODUCTIVE HEALTH CARE IN COLORADO to implement Colorado Senate Bill 23-188 (Concerning Protections for Accessing Reproductive Health Care) and Rule 1.21 - PROTECTING COLORADO’S WORKFORCE AND EXPANDING LICENSING OPPORTUNITIES to implement Colorado Senate Bill 23-265 (Concerning a Prohibition on a Regulator Imposing Discipline Against a Person Based on Certain Activities Involving Marijuana) and to consider adopting the proposed changes to Rule 1.11 - SUPERVISION OF COLLABORATIVE AGREEMENTS AND PRACTICE BY PHYSICIAN ASSISTANTS (PAs) to implement Colorado Senate Bill 23-083 (Concerning an Expansion of a Physician Assistant’s Ability to Practice, and, in Connection Therewith, Changing the Relationship Between a Physician Assistant and a Physician or Podiatrist from Supervision to Collaboration).
- Friday, November 3, 2023, at 12:00 P.M. (MDT)
- Permanent Rulemaking Hearing Notice
- Draft Rules
- Written comments regarding SB23-188 (Links will be updated as comments are received.)
- Written comments regarding SB23-265 (Links will be updated as comments are received.)
REQUESTING WRITTEN STAKEHOLDER COMMENTS AND NOTICE OF EMERGENCY RULEMAKING HEARING ON SEPTEMBER 8, 2023
What is this about?
The Colorado Board of Podiatry ("Board") is requesting written comments regarding proposed revisions to Rule 1.11, Supervision and Practice by Physician Assistants (PAs), to implement Colorado Senate Bill 23-083 (CONCERNING AN EXPANSION OF A PHYSICIAN ASSISTANT'S ABILITY TO PRACTICE, AND, IN CONNECTION THEREWITH, CHANGING THE RELATIONSHIP BETWEEN A PHYSICIAN ASSISTANT AND A PHYSICIAN OR PODIATRIST FROM SUPERVISION TO COLLABORATION); proposed repeal of Rule 1.20, Provision of Reproductive Health Care in Colorado, to implement Colorado Senate Bill 23-188 (CONCERNING PROTECTIONS FOR ACCESSING REPRODUCTIVE HEALTH CARE), and proposed repeal of Rule 1.21, Protecting Colorado's Workforce and Expanding Licensing Opportunities, to implement Colorado Senate Bill 23-265 (CONCERNING A PROHIBITION ON A REGULATOR IMPOSING DISCIPLINE AGAINST A PERSON BASED ON CERTAIN ACTIVITIES INVOLVING MARIJUANA).
The Board held an Emergency Rulemaking Hearing on September 8, 2023, to determine whether to adopt only the proposed revisions to Rule 1.11 on an emergency basis. At the Emergency Rulemaking Hearing, the Board adopted the revisions to Rule 1.11 on an emergency basis. The emergency rule revisions to Rule 1.11 took effect on September 8, 2023. The Permanent Rulemaking Hearing is scheduled for November 3, 2023, where the Board will decide whether to adopt the proposed revisions to Rules 1.11, 1.20, and 1.21 on a permanent basis. The Board will continue to accept written comments regarding all of the proposed rule changes. Please send your written comments to dora_dpo_rulemaking@state.co.us.
Joint Stakeholder Meeting - Opioid Guidelines - July 17, 2023
The Colorado State Board of Pharmacy, Colorado Dental Board, Colorado Medical Board, Colorado State Board of Nursing, Colorado State Board of Optometry, Colorado Podiatry Board, and Colorado State Board of Veterinary Medicine are holding a virtual Stakeholder Meeting on July 17, 2023, for stakeholders to provide feedback regarding Colorado’s Guidelines for the Safe Prescribing and Dispensing of Opioids as these guidelines relate to the United States Centers for Disease Control and Prevention’s (CDC) updated Clinical Practice Guideline for Prescribing Opioids for Pain.
- Stakeholder Meeting notice: Monday, July 17, 2023, at 12:30 p.m.
- Stakeholder Written Comments (Link will be updated weekly as comments are received.)
- Stakeholder Meeting Recording
- Legislative Updates
- 2023 New Legislation
- 2022 New Legislation
- HB22-1041: Privacy Protections For Protected Persons
- HB22-1098: Department Of Regulatory Agencies Barriers To Practice Regulated Professions
- HB22-1165 Rule Review Bill
- HB22-1240 Mandatory Reporters
- HB22-1267 Culturally Relevant Training Health Professionals
- HB22-1270 Change Term Name-based Criminal History Record Check
- HB22-1278: Behavioral Health Administration
- HB22-1291: Sunrise Review Professions Occupations
- SB22-013: Boards and Commissions
- SB22-027: Prescription Drug Monitoring Program
- SB22-076: Complaint Occupational License Official Acts
- SB22-116: Increase Occupational Credential Portability
- SB22-143: Update Common Provision Term Regulator Title 12
- SB22-162: Administration Organization Act Modernization
- SB22-174: Sunset Review Hearing Criteria
- SB22-226: Programs To Support Health-care Workforce
- 2021 New Legislation
- HB21-1012: Expand Prescription Drug Monitoring Program
- HB 21-1123: CAPS Check for Substantiated Cases of Mistreatment of an At-Risk Adult
- HB21-1169: Prohibit Discrimination Organ Transplant Recipient
- HB21-1198: Healthcare Billing Requirements for Indigent Patients
- HB21-1232: Standardized Health Benefit Plan Colorado Option
- HB21-1276 Prevention of Substance Use Disorders
- HB21-1297: Pharmacy Benefit Manager and Insurer Requirements
- HB21-1300: Health-care Provider Liens for Injured Persons
- SB21-097: Sunset Medical Transparency Act
- SB21-011: Pharmacist Prescribe Dispense Opiate Antagonist
- SB21-077: Remove Lawful Presence Verification Credentialing
- SB21-094: Sunset Continue State Board of Pharmacy
- SB21-098: Sunset Prescription Drug Monitoring Program
- SB21-122: Opiate Antagonist Bulk Purchase And Standing Orders
- SB21-271: Misdemeanor Reform
- 2020 New Legislation
- Meeting Minutes